Insights for Navigating an Uncertain World
“BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University of Pennsylvania over the payment of royalties related to its COVID-19 vaccine, the company said in filings.”
Hmm. I wonder if such arrangements between an agency that approves medical products and the company that produces them creates any perverse incentives…
BioNTech enters settlement with US agency, UPenn over COVID vaccine royalties | Reuters
Mark Skidmore is Professor of Economics at Michigan State University where he holds the Morris Chair in State and Local Government Finance and Policy. His research focuses on topics in public finance, regional economics, and the economics of natural disasters. Mark created the Lighthouse Economics website and blog to share economic research and information relevant for navigating tumultuous times. View more posts
Subscribe now to keep reading and get access to the full archive.